Hyperbaric Oxygen Therapy in Cancer Research

Sep 14, 2024

Psychobaric Boxing Therapy and Cancer Treatment

Introduction

  • Topic: Hyperbaric Oxygen Therapy (HBOT) in Cancer Treatment
  • Unfamiliar for many hyperbaric physicians
  • Over 1000 articles since 1950, indicating significant research

Hyperbaric Oxygen Therapy (HBOT)

  • Characterized as a genomic drug, affecting DNA and chromosomes
  • Known for metabolic and genomic effects
  • Has a unique purity and is necessary for life

Cancer and Genomic Foundation

  • Cancer: Abnormal cells divide uncontrollably, invade tissues
  • Described as a genetic disease affecting oncogenes, tumor suppressor genes, and stability genes
  • Role of epigenetics: Changes in gene expression without altering DNA sequences
    • Changes occur at the histones, affecting gene transcription

Cancer Biology and Hypoxia

  • Hypoxia plays a critical role in tumor development
  • Warburg Effect: Cancer cells prefer glycolysis over mitochondrial respiration
  • Hypoxia causes gene regulation changes, affecting cancer progression
  • Tumor hypoxia affects efficacy of chemotherapy and radiation

Reactive Oxygen Species (ROS)

  • Induced by hypoxia and reperfusion
  • ROS cause DNA strand breaks, mutations
  • High ROS levels lead to apoptosis, key in cancer therapy

HBOT in Cancer Treatment

  • Benefits: Increases ROS, enhances chemotherapy and radiation by improving oxygenation
  • Animal Studies: Show inhibitory or neutral effects on tumors; some stimulatory effects in mouse models
  • Human Studies: Support inhibitory or neutral effects

HBOT and Radiation Therapy

  • Enhances effectiveness by increasing oxygen levels
  • Used historically, now gaining traction in treatment of aggressive cancers like glioblastoma

Chemotherapy and HBOT

  • Increases tumor perfusion, potentially enhancing chemotherapy effectiveness
  • May reduce side effects of chemotherapy

Photodynamic Therapy

  • Dependent on tumor oxygenation
  • HBOT improves effectiveness by increasing oxygen supply

Conclusion

  • HBOT shows potential as an adjunct therapy in cancer treatment, particularly with chemo and radiation
  • Results depend on cancer type, stage, and treatment timing
  • Despite years of research, more studies are needed to fully understand and optimize HBOT in cancer therapy

Key Takeaways

  • Cancer is largely genetic, influenced by epigenetic factors
  • HBOT can aid treatment by addressing hypoxia, enhancing other therapies
  • Ongoing research is crucial to establish effective protocols